AIDS‐associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa
Open Access
- 1 January 2010
- journal article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 13 (1), 23
- https://doi.org/10.1186/1758-2652-13-23
Abstract
AIDS-associated Kaposi's sarcoma is an important, life-threatening opportunistic infection among people living with HIV/AIDS in resource-limited settings. In western countries, the introduction of combination antiretroviral therapy (cART) and new chemotherapeutic agents has resulted in decreased incidence and improved prognosis of AIDS-associated Kaposi's sarcoma. In African cohorts, however, mortality remains high. In this study, we describe disease characteristics and risk factors for mortality in a public sector HIV programme in South Africa.Keywords
This publication has 16 references indexed in Scilit:
- Cancer incidence in people with AIDS in ItalyInternational Journal of Cancer, 2010
- Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiationCurrent Opinion in HIV and AIDS, 2009
- Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyBritish Journal of Cancer, 2008
- Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy eraAIDS, 2008
- The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003Cancer, 2004
- Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's SarcomaJournal of Clinical Oncology, 2004
- AIDS-Related Kaposi’s Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging System in the Haart Era—the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve From AntiretroviralsJournal of Clinical Oncology, 2003
- Effect of highly active antiretroviral therapy on survival among HIV‐infected men with Kaposi sarcoma or non‐Hodgkin lymphomaInternational Journal of Cancer, 2002
- Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitorAIDS, 2002
- AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.Journal of Clinical Oncology, 1997